Analysis
Joshua Kushner picked an interesting week to warn the rest of Silicon Valley about AI euphoria. In Thrive Capital's first-ever investor letter, Kushner criticized what he characterized as excessive enthusiasm among West Coast venture rivals -- and I think he's directionally right about the underlying problem, even though the messenger has some explaining to do.
Here's what makes the timing genuinely interesting rather than just ironic: Thrive isn't a bystander in the AI euphoria it's describing. The firm co-led Thrive Holdings' $2 billion OpenAI-backed raise earlier this month and carries significant exposure to both Anthropic and OpenAI across its funds. That's not a disqualifying conflict -- plenty of the most useful critiques of a market come from people who are deeply positioned in it, because they can see the mechanics up close. But it does mean Kushner's letter reads less like an outside observer sounding an alarm and more like an insider trying to draw a line between his own firm's conviction bets and what he sees as everyone else's momentum chasing.
The pattern he appears to be describing is real and I've flagged versions of it myself:
“Here's what makes the timing genuinely interesting rather than just ironic: Thrive isn't a bystander in the AI euphoria it's describing.”
- Databricks -- repriced from $134 billion to $190 billion in six months
- Cognition -- moved from $26 billion to reported $40 billion talks in three months
- Lovable -- confirmed a fresh $13.3 billion mark weeks after its last one
Valuation cycles that used to take 18-24 months are now compressing into weeks, and that compression is a symptom of capital chasing a narrow set of AI leaders faster than any of them can actually prove out the growth those marks assume.
Room for disagreement: Kushner's own firm is a direct beneficiary of exactly the dynamic he's criticizing -- Thrive's positions in OpenAI and Anthropic have appreciated substantially because of the same euphoria he's now warning about, and there's a reasonable read where 'euphoria' is simply what Kushner calls other funds' enthusiasm for deals Thrive didn't get into, while his own large positions get framed as conviction. It's also worth noting that a fund's first-ever investor letter is, among other things, a marketing document aimed at current and prospective LPs -- positioning Thrive as the disciplined adult in the room is good LP messaging regardless of whether the underlying critique is fully consistent.
For founders and GPs reading this: take the substance of the warning seriously -- compressed repricing cycles are a real risk to anyone marking NAV off recent rounds -- and discount the framing accordingly. The mechanism he's describing is worth watching closely regardless of who's pointing at it.
